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biological properties of existing markers in greater detail. Several
papers described novel roles for chemotactic proteins (i.e. monocyte
chemotactic protein 1, MCP1) and complement proteins as novel
biomarkers. The dysregulation of complement components, especially
the ‘membrane attack complex’ (MAC), which colocalizes with matrix
metalloprotease 13 (MMP-13) in OA cartilage implicates this compo-
nent of complement in the pathogenesis of OA. Associations between
inﬂammatory markers from skeletal muscle and knee OA support the
contribution of inﬂammatory mediators from muscle to the disease
process. Quantitative and high-throughput proteomic techniques
continue to make important contributions to the discovery of comple-
ment components, lipoproteins and lower abundance extracellular
matrix (ECM) components in serum from OA patients. There is ongoing
interest in serum cartilage oligomeric matrix protein (sCOMP) and
deamidated COMP (D-COMP). A systematic review and meta-analysis
conﬁrmed that sCOMP is elevated in patients with knee OA. Enrichment
of the deamidated epitope of COMP has led to the suggestion that D-
COMP is the ﬁrst biomarker to show speciﬁcity for particular joint sites.
The development of new chip-based COMP immunoassays is also likely
to contribute to improvements in diagnostic assays for COMP in serum,
synovial ﬂuid and urine. Fibulin-3 peptides (Fib3-1 and Fib3-2) have
been proposed as potential biomarkers of OA along with follistatin-like
protein 1 (FSTL1), a new serum biomarker with the capacity for
reﬂecting the severity of joint damage. The xylosyltransferase and
transglutaminase enzymes are also under investigation as markers for
monitoring tissue remodelling in OA and as early biomarkers in mouse
models of posttraumatic OA.
Conclusion: The last eightmonths have seen steady progress in the area
of OA biomarker research. Proteomic screening techniques are making
signiﬁcant contributions to the discovery of novel OA biomarkers in
serum and urine. More traditional screening methods such as the phage
display technique are also revealing new biomarkers. Many of the
biomarkers identiﬁed thus far reﬂect catabolic events during the process
of cartilage degradation in the later stages of OA. It is important to
recognize that some biomarkers will be indicators of normal cartilage
turnover, tissue repair, or ECM remodelling and we need to be able to
discriminate between catabolic and maintenance events. The deﬁnition
of ‘biomarker’ will need to reﬂect these diverse processes and the vali-
dation and qualiﬁcation processes for novel biomarkers will ultimately
depend on the context and speciﬁc purpose of their intended applica-
tions. There is an acute need for new biochemical markers that are
involved in early responses in cartilage. New biomarkers require vali-
dation according to the ‘BIPEDS’ (Burden of Disease, Investigative,
Prognostic, Efﬁcacy of Intervention and Diagnostic and Safety) criteria
for detecting early, pre-radiographic changes in joints. Combining
biochemical markers with tissue and cell imaging techniques and bio-
informatics (i.e. machine learning, clustering, data visualization) is likely
to increase the predictive power of future ‘combination biomarkers’.
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Purpose: This presentation reviews the original publications related to
imaging in osteoarthritis published in English between September 2011
and April 2012. In vitro data and animal studies will not be covered.
Methods: To select relevant studies, an extensive Pubmed database
search was performed using the query terms “Osteoarthritis” in
conjunction with “MRI”, “Imaging”, “Radiography”, “Ultrasound”,
“Computed Tomography” and “Nuclear Medicine”. Papers were sorted
according to relevance based on potential impact to the OA research
community with the overarching goal of a balanced overview covering
all aspects of imaging.The literature will be presented by topics covering systematic reviews,
radiography, hip OA, compositional and high ﬁeld MRI, morphologic
and quantitative knee MRI, hand OA, and others.
Results: Using the search topics “MRI” and “Osteoarthritis” a decrease
in overall publications was observed over the 6 months since
September 2011 when compared to the previous 6 months (38.1%, 117
vs 189). Using the terms “Radiography” and “Osteoarthritis” a decrease
of 56.9% (154 vs 358)was seen. One likely explanation could be the close
interval between the OARSI meetings 2011 and 2012, which means that
a lot of the presented research work from OARSI 2011 is still under
review and likely to be published in the 2nd half of 2012.
A systematic meta-analysis showed high speciﬁcity and moderate
sensitivity of MRI when compared to various reference standards
stating that currently the standard clinical algorithm for OA diagnosis,
aided by radiographs appears to be the most effective method for
diagnosing OA.
A study analyzing joint shape from radiographs in women showed
that OA knees were wider, more extended during radiography and
had an elevated lateral tibial plateau, which suggests that joint shape
is involved in the OA process. Comparing centralized vs. site reading
of knee radiographs, different thresholds for detecting osteophytes
and joint space between the site investigators and a centralized
reader in a multicenter setting were reported stressing the advan-
tage of centralized reading to ensure comparability of image
assessment.
One study analyzed hip joints of asymptomatic young men in regard to
cam-type deformities and MRI-detected articular damage, and showed
that these deformities were associated with labral lesions, impinge-
ment pits and decreased cartilage thickness.
Several studies have focused on compositional MRI techniques. T2
mapping data from the large Osteoarthritis Initative are being analyzed
and reported associations between compositional measurements and
structural changes. Newer techniques are being explored including in
vivo diffusion tensor imaging of cartilage and sodium imaging at high
ﬁeld MRI.
Some epidemiologic studies assessed systemic factors and joint health.
One study reported that energy, carbohydrate and sugar intake may be
risk factors for bone marrow lesion (BML) development and progres-
sion. Based on the results of another study, parity was independently
associated with lower cartilage volume primarily in the tibial
compartment and higher cartilage defects in the patella compartment
in a population-based sample of older women.
New insights about the role of inﬂammation in OA were reported by
several groups. One study showed that only contrast enhanced MRI was
able to detect microspcopically proven synovitis. Another group
showed that synovitis is a characteristic feature of advanced knee OA
and is signiﬁcantly associated with radiographic OA features and total
volume of BMLs. For knees without osteoarthritis joint effusion seems
to have a negative impact on cartilage loss and thus might be an
important feature in disease initiation.
Assessing MRI-based risk factors for semiquantitatively detected carti-
lage loss over 6 months it was reported that BMLs, effusion-synovitis
and meniscal extrusion increased risk for ipsi-compartmental cartilage
loss.
Studies using quantitative methodology suggested a relationship
between extrusion of the meniscal body and knee pain in subjects with
knee OA and also reported greater rates of cartilage loss for subjects
with knee pain. In addition novel techniques for automated bone
segmentation have been reported.
Only few studies have focused on ultrasound applications in OA and
other imaging methods. Additional studies that will be covered in this
review have focused on hand OA, osteophyte prevalence, crepitus, joint
injury as well as patello-femoral OA. Intentionally, original research that
will be presented as a podium or poster presentation at OARSI 2012 will
not be part of this review.
